We further verified that KN93 had dramatic effectiveness in two AP mouse models and that it decreases the expression of necrotic complexes (RIP3 and p-MLKL) in two cell lines, providing a new target for the prevention and treatment of AP in the clinic. The gene discussed is MLKL; the disease is alkaline phosphatase measurement.